Literature DB >> 9636324

Development of new cloning vectors for the production of immunogenic outer membrane fusion proteins in Escherichia coli.

P Cornelis1, J C Sierra, A Lim, A Malur, S Tungpradabkul, H Tazka, A Leitão, C V Martins, C di Perna, L Brys, P De Baetseller, R Hamers.   

Abstract

The Pseudomonas aeruginosa lipoprotein gene (oprI) was modified by cloning an in-frame polylinker in both orientations at the end of oprI. The resulting plasmids pVUB1 and pVUB2 allow high lipoprotein production in E. coli after IPTG induction. The modified lipoproteins are present in the outer membrane and surface-exposed. Outer membrane-bound fusion proteins of different sizes were produced and used to generate antibodies without use of adjuvant. An 87 bp DNA fragment from the vp72 capsid protein gene of African Swine Fever virus (ASFV) and the entire Leishmania major glycoprotein gp63 gene were expressed in this system. Finally, a fusion lipoprotein containing a 16 amino acid epitope from the pre-S2b region of Hepatitis B virus (HBV) was presented by an antigen-presenting cell line to a T-cell hybridoma while the corresponding cross-linked S2b peptide was not. The results suggest that OprI-based fusion proteins can be used to generate both humoral and cellular immune responses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9636324     DOI: 10.1038/nbt0296-203

Source DB:  PubMed          Journal:  Biotechnology (N Y)        ISSN: 0733-222X


  10 in total

1.  Cellular locations of Pseudomonas syringae pv. syringae HrcC and HrcJ proteins, required for harpin secretion via the type III pathway.

Authors:  W L Deng; H C Huang
Journal:  J Bacteriol       Date:  1999-04       Impact factor: 3.490

2.  Antigen 43-mediated autotransporter display, a versatile bacterial cell surface presentation system.

Authors:  Kristian Kjaergaard; Henrik Hasman; Mark A Schembri; Per Klemm
Journal:  J Bacteriol       Date:  2002-08       Impact factor: 3.490

Review 3.  Colicin import into Escherichia coli cells.

Authors:  C J Lazdunski; E Bouveret; A Rigal; L Journet; R Lloubès; H Bénédetti
Journal:  J Bacteriol       Date:  1998-10       Impact factor: 3.490

4.  Sequestration of zinc oxide by fimbrial designer chelators.

Authors:  K Kjaergaard; J K Sørensen; M A Schembri; P Klemm
Journal:  Appl Environ Microbiol       Date:  2000-01       Impact factor: 4.792

5.  Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae.

Authors:  K E Conrath; M Lauwereys; M Galleni; A Matagne; J M Frère; J Kinne; L Wyns; S Muyldermans
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

6.  Bacterial lipoprotein-based vaccines induce tumor necrosis factor-dependent type 1 protective immunity against Leishmania major.

Authors:  Javier Cote-Sierra; Amin Bredan; Carmen M Toldos; Benoit Stijlemans; Lea Brys; Pierre Cornelis; Manuel Segovia; Patrick de Baetselier; Hilde Revets
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

7.  Immune response to an 18-kilodalton outer membrane antigen identifies lipoprotein 20 as a Helicobacter pylori vaccine candidate.

Authors:  J Keenan; J Oliaro; N Domigan; H Potter; G Aitken; R Allardyce; J Roake
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

Review 8.  Strategies for achieving high-level expression of genes in Escherichia coli.

Authors:  S C Makrides
Journal:  Microbiol Rev       Date:  1996-09

9.  Selective infection of antigen-specific B lymphocytes by Salmonella mediates bacterial survival and systemic spreading of infection.

Authors:  Yuri Souwer; Alexander Griekspoor; Jelle de Wit; Chiara Martinoli; Elena Zagato; Hans Janssen; Tineke Jorritsma; Yotam E Bar-Ephraïm; Maria Rescigno; Jacques Neefjes; S Marieke van Ham
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

Review 10.  Targeting TLR2 for vaccine development.

Authors:  Afonso P Basto; Alexandre Leitão
Journal:  J Immunol Res       Date:  2014-06-26       Impact factor: 4.818

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.